A phase II study combining bendamustine and obinutuzumab showed promising results in patients with previously untreated chronic lymphocytic leukemia (CLL). Dr. Jeff Sharman, the director of research at WVCI and the medical director of hematology research for The US Oncology Network, discussed the results of the GIBB trial at the 2017 American Society of Hematology.
No one wants to face the prospect of a cancer diagnosis, especially when recovery means a long treatment regimen that may include surgery, chemotherapy and/or radiation. All of these treatments, while they can be life-saving, come with side effects that are less than desirable. The good news is that developing and maintaining some healthy habits can help you reduce the.
Many people who are diagnosed with breast cancer want to continue working, whether for a sense of normalcy or because of financial necessity. But there are often issues that arise while working during and after treatment and returning to work after taking an extended leave from the workplace. Susan G. Komen Oregon & SW Washington is hosting a forum on Sat., Oct. 22 at the.
Clinical trials are the centerpiece for the drug-testing system in the United States. Each cancer study conducted tries to answer scientific questions and determine better ways to prevent, diagnose or treat the disease. As researchers test the effectiveness of trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they.
With skin cancer being the most common of all cancers, protecting yourself from the sun is something to think about all year long, especially on these hot, summer days. According to a survey by the CDC in 2008, only a third of adults report using sunscreen regularly. However, getting even a single sunburn increases your risk of developing melanoma—the deadliest form of.